Concepedia

Jiaqin Yan

JY

Statistics

Publications

30

Citations

993

H-Index

18

Active since

2011

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

The University of Texas MD Anderson Cancer Center

Henan Cancer Hospital

PersonGen (China)

Jiaqin Yan is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and lymphoid neoplasms.

Publications per year

2011–2023

30

Publications

30

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Xin Li, Mingzhi Zhang, Jiaqin Yan et al. · Journal of Hematology & Oncology · 2018 · 197 citations · Full text

, , +17

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Dan Chen, Xiaorui Fu et al. · Clinical Cancer Research · 2022 · 113 citations · Full text

, , +17

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 58 citations · Full text

, , +13

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

Zhi‐Yuan Zhou, Xiang Li, Changying Chen et al. · Annals of Hematology · 2014 · 52 citations

, , +14

Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

Jingjing Wu, Wenhua Wang, Meng Dong et al. · Investigational New Drugs · 2022 · 44 citations

, , +15

1–5 of 30